B cells and antibodies in CNS demyelinating disease

被引：180

作者：

Cross, AH ^{[1
]}

Trotter, JL ^{[1
]}

Lyons, JA ^{[1
]}

机构：

[1] Washington Univ, Sch Med, Dept Neurol & Neurosurg, St Louis, MO 63110 USA

来源：

JOURNAL OF NEUROIMMUNOLOGY | 2001年 / 112卷 / 1-2期

关键词：

multiple sclerosis; experimental autoimmune encephalomyelitis; B cell; plasma cell; antibody;

D O I：

10.1016/S0165-5728(00)00409-4

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

There is much evidence to implicate B cells, plasma cells, and their products in the pathogenesis of MS. Despite unequivocal evidence that the animal model for MS, EAE, is initiated by myelin-specific T cells, there is accumulating evidence of a role for B cells, plasma cells, and their products in EAE pathogenesis. The role(s) played by B cells, plasma cells, and antibodies in CNS inflammatory demyelinating diseases are likely to be multifactorial and complex, involving distinct and perhaps opposing roles for B cells versus antibody. (C) 2001 Elsevier Science B.V. All rights reserved.

引用

页码：1 / 14

页数：14

共 50 条

[21] NG2-positive cells in CNS function and the pathological role of antibodies against NG2 in demyelinating diseases [J].

Trotter, J .

JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 233 (1-2) :37-42

[22] The Role of Peripheral CNS-Directed Antibodies in Promoting Inflammatory CNS Demyelination [J].

Kinzel, Silke ;

Weber, Martin S. .

BRAIN SCIENCES, 2017, 7 (07)

[23] Demyelinating CNS Lesions in a Teenager [J].

Ren, Dennis ;

Steele, Russell W. .

CLINICAL PEDIATRICS, 2017, 56 (02) :194-197

[24] Primary demyelinating disorder of the CNS [J].

Nassim, Eman .

NEUROSCIENCES, 2015, 20 (03) :298-299

[25] TNFR2 signaling in oligodendrocyte precursor cells suppresses their immune-inflammatory function and detrimental microglia activation in CNS demyelinating disease [J].

Desu, Haritha L. ;

Thougaard, Estrid ;

Carney, Brianna N. ;

Illiano, Placido ;

Plastini, Melanie J. ;

Florimon, Yoleinny ;

Mini, Antonella ;

Guastucci, Chelsea ;

Kang, Brian ;

Lee, Jae K. ;

Lambertsen, Kate L. ;

Brambilla, Roberta .

BRAIN BEHAVIOR AND IMMUNITY, 2025, 123 :81-98

[26] Therapeutic Apheresis in Pediatric Patients with Acute CNS Inflammatory Demyelinating Disease [J].

Koziolek, Michael ;

Muehlhausen, Johannes ;

Friede, Tim ;

Ellenberger, David ;

Sigler, Matthias ;

Huppke, Brenda ;

Gaertner, Jutta ;

Mueller, Gerhard-Anton ;

Huppke, Peter .

BLOOD PURIFICATION, 2013, 36 (02) :92-97

[27] Low-field portable brain MRI in CNS demyelinating disease [J].

Mateen, Farrah J. ;

Cooley, Clarissa Zimmerman ;

Stockmann, Jason P. ;

Rice, Dylan R. ;

Vogel, Andre C. ;

Wald, Lawrence L. .

MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 51

[28] Nalfurafine reduces neuroinflammation and drives remyelination in models of CNS demyelinating disease [J].

Denny, Lisa ;

Al Abadey, Afnan ;

Robichon, Katharina ;

Templeton, Nikki ;

Prisinzano, Thomas E. ;

Kivell, Bronwyn M. ;

La Flamme, Anne C. .

CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2021, 10 (01)

[29] Demyelinating Disease and Hepatitis B VaccinationIs There a Link? [J].

Tom Jefferson ;

Harald Heijbel .

Drug Safety, 2001, 24 :249-254

[30] Hepatitis B vaccine not linked to demyelinating disease [J].

Reactions Weekly, 1999, 773 (1) :5-5

← 1 2 3 4 5 →